Stock Events

Stock Events

BioXcel Therapeutics (BX2.F) Q3 2024 Earnings

6AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.81

-0.6

-0.4

-0.19

Details

Expected EPS

-0.65218132664

Actual EPS

-0.19220459999999998

Surprise EPS

0.46

Surprise Percent

+70.53%

Description

BioXcel Therapeutics (BX2.F) has reported earnings of -0.19220459999999998 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.